Sign Up Today and Learn More About ZetaGen Therapeutics Stock
Invest in or calculate the value of your shares in ZetaGen Therapeutics or other pre-IPO companies through EquityZen's platform.
ZetaGen Therapeutics Stock (ZETH)
ZetaGen Therapeutics commercializes a small molecule-based osteoinductive platform.
About ZetaGen Therapeutics Stock
Founded
2015
Headquarters
Syracuse, NY, US
Industries
Software, Artificial Intelligence, Data and Analytics
ZetaGen Therapeutics Press Mentions
Stay in the know about the latest news on ZetaGen Therapeutics
Zetagen Therapeutics Shares In-vivo Dose Optimization Data of ZetaMAST™ (Zeta-MBC-005) Metastatic Breast Cancer in Liver
biospace • Dec 10, 2024
Zetagen Therapeutics Announces First Patients Enrolled in Phase 2a Clinical Study of ZetaMet™ (Zeta-BC-003) Metastatic Breast Cancer
businesswire • Nov 12, 2024
Methods and compositions to graft bone using iron excipients
patents • Apr 14, 2024
Methods and compositions for treating cancer
patents • Apr 14, 2024
Zetagen Announces Publication in Pain Management of Early ...
businesswire • Dec 21, 2023
ZetaGen Therapeutics Management
Leadership team at ZetaGen Therapeutics
Co-Founder & Chief Medical Officer
Nikhil Thakur
Chief Executive Officer
Joe Loy
Join now and verify your accreditation status to gain access to:
- ZetaGen Therapeutics current valuation
- ZetaGen Therapeutics stock price
- Available deals in ZetaGen Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading ZetaGen Therapeutics Stock
How to invest in ZetaGen Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like ZetaGen Therapeutics through EquityZen funds. These investments are made available by existing ZetaGen Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell ZetaGen Therapeutics stock?
Shareholders can sell their ZetaGen Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
